Published in Clin Vaccine Immunol on March 29, 2017
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature (2008) 10.80
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature (2009) 9.51
Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis (2011) 6.06
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature (2013) 5.35
Rational HIV immunogen design to target specific germline B cell receptors. Science (2013) 3.55
The WHO 2014 global tuberculosis report--further to go. Lancet Glob Health (2015) 2.97
The role of somatic hypermutation in the generation of antibody diversity. Science (1989) 2.55
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science (2016) 2.53
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol (2014) 2.34
Proof of principle for epitope-focused vaccine design. Nature (2014) 2.09
The generation of antibody-secreting plasma cells. Nat Rev Immunol (2015) 1.87
In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire. Nat Med (2014) 1.81
Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J Virol (2012) 1.74
Vaccines and vaccination against yellow fever. WHO position paper -- June 2013. Wkly Epidemiol Rec (2013) 1.71
Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J (1990) 1.70
Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature (2014) 1.65
Dynamics of B cells in germinal centres. Nat Rev Immunol (2015) 1.61
Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature (2016) 1.52
Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc Natl Acad Sci U S A (2014) 1.50
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A (2016) 1.31
Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans. Immunity (2015) 1.18
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science (2016) 1.10
B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts. J Virol (2016) 1.00
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science (2016) 0.97
Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus. Cell Host Microbe (2015) 0.95
A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies. MBio (2015) 0.95
Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat Med (2016) 0.93
Two-mAb cocktail protects macaques against the Makona variant of Ebola virus. Sci Transl Med (2016) 0.91
Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires. Proc Natl Acad Sci U S A (2016) 0.90
The Diversity and Molecular Evolution of B-Cell Receptors during Infection. Mol Biol Evol (2016) 0.89
Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction. J Infect Dis (2016) 0.87
Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination. Nat Immunol (2016) 0.82
Direct high-throughput amplification and sequencing of immunoglobulin genes from single human B cells. Eur J Immunol (2015) 0.82
Sequencing and cloning of antigen-specific antibodies from mouse memory B cells. Nat Protoc (2016) 0.80
A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve. Nat Commun (2016) 0.76